News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
26,637 Results
Type
Article (1407)
Company Profile (3)
Press Release (25227)
Section
Business (12718)
Career Advice (15)
Deals (1821)
Drug Delivery (18)
Drug Development (2967)
Employer Resources (1)
FDA (466)
Job Trends (650)
News (17343)
Policy (950)
Tag
Academia (37)
Accelerated approval (1)
Allergies (1)
Alliances (1252)
ALS (1)
Alzheimer's disease (24)
Antibody-drug conjugate (ADC) (3)
Approvals (473)
Artificial intelligence (7)
Autoimmune disease (3)
Bankruptcy (2)
Best Places to Work (527)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (1)
Bladder cancer (3)
Brain cancer (1)
Breast cancer (10)
Cancer (110)
Cardiovascular disease (15)
Career advice (14)
CAR-T (4)
Cell therapy (11)
Clinical research (2654)
Collaboration (25)
Compensation (19)
COVID-19 (35)
CRISPR (2)
C-suite (4)
Cystic fibrosis (3)
Data (167)
Depression (5)
Diabetes (20)
Diagnostics (172)
Digital health (2)
Drug discovery (6)
Drug pricing (3)
Drug shortages (8)
Duchenne muscular dystrophy (4)
Earnings (11141)
Editorial (6)
Employer resources (1)
Events (1909)
Executive appointments (7)
FDA (631)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (22)
Gene editing (5)
Gene therapy (2)
GLP-1 (55)
Government (73)
Guidances (121)
Healthcare (568)
HIV (1)
Huntington's disease (2)
IgA nephropathy (3)
Immunology and inflammation (12)
Immuno-oncology (2)
Indications (3)
Infectious disease (41)
Inflammatory bowel disease (3)
Intellectual property (7)
Interviews (1)
IPO (1220)
IRA (1)
Job creations (159)
Job search strategy (14)
Kidney cancer (3)
Labor market (1)
Layoffs (12)
Legal (190)
Liver cancer (1)
Lung cancer (20)
Lymphoma (14)
Manufacturing (38)
MASH (4)
Medical device (579)
Medtech (583)
Mergers & acquisitions (625)
Metabolic disorders (65)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (7)
Neuropsychiatric disorders (4)
Neuroscience (51)
NextGen: Class of 2026 (155)
Non-profit (51)
Obesity (45)
Opinion (4)
Ovarian cancer (1)
Pain (3)
Pancreatic cancer (3)
Parkinson's disease (2)
Partnered (1)
Patents (5)
Patient recruitment (7)
Peanut (1)
People (1150)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (705)
Phase 2 (1110)
Phase 3 (1001)
Pipeline (488)
Policy (4)
Postmarket research (92)
Preclinical (228)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (5)
Rare diseases (26)
Real estate (178)
Recruiting (1)
Regulatory (774)
Reports (2)
Research institute (21)
Resumes & cover letters (1)
Rett syndrome (2)
RSV (5)
Schizophrenia (4)
Series A (7)
Series B (1)
Special edition (1)
Spinal muscular atrophy (13)
Sponsored (1)
Startups (121)
Supply chain (11)
Tariffs (2)
The Weekly (2)
Vaccines (18)
Venture capital (4)
Weight loss (41)
Women's health (2)
Date
Today (2)
Last 7 days (24)
Last 30 days (75)
Last 365 days (1255)
2026 (93)
2025 (1267)
2024 (1574)
2023 (1658)
2022 (1791)
2021 (1912)
2020 (1715)
2019 (1326)
2018 (1010)
2017 (1984)
2016 (4485)
2015 (638)
2014 (421)
2013 (262)
2012 (349)
2011 (357)
2010 (419)
Location
Africa (22)
Alabama (1)
Arizona (3)
Asia (1397)
Australia (189)
California (505)
Canada (102)
China (45)
Colorado (64)
Connecticut (29)
Delaware (13)
Europe (3438)
Florida (97)
Georgia (15)
Idaho (1)
Illinois (33)
India (3)
Indiana (34)
Japan (12)
Kansas (3)
Kentucky (2)
Louisiana (2)
Maine (1)
Maryland (55)
Massachusetts (305)
Michigan (9)
Minnesota (30)
Missouri (3)
Nevada (3)
New Hampshire (6)
New Jersey (115)
New York (101)
North Carolina (49)
Northern California (314)
Ohio (17)
Pennsylvania (95)
South America (34)
Southern California (153)
Tennessee (2)
Texas (48)
United States (1657)
Utah (20)
Virginia (10)
Washington D.C. (2)
Washington State (40)
Wisconsin (3)
26,637 Results for "165".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions
December 19, 2025
·
4 min read
Press Releases
Ember LifeSciences secures $16.5 million Series A funding to advance breakthrough cold chain solutions for global healthcare
December 17, 2025
·
2 min read
Circle Pharma Announces Nomination of CID-165, an Oral First-in-class Cyclin D1 RxL Inhibitor, as Development Candidate for its Second Oncology Program
December 18, 2025
·
2 min read
Press Releases
Expedition Therapeutics Raises $165 Million in Oversubscribed Series A Financing to Advance Next-Generation DPP1 inhibitor for COPD
October 10, 2025
·
4 min read
Earnings
Catalent Misses Fiscal Q1 Revenue Expectations as Pressure Mounts on Novo Holdings’ $16.5B Buyout
The contract manufacturer fell short of Wall Street’s projections for its first quarter of fiscal 2025, which ended Sept. 30, 2024. The miss comes amid growing opposition to Novo Holdings’ proposed $16.5 billion acquisition of Catalent.
November 6, 2024
·
3 min read
·
Tristan Manalac
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
Novartis and Argo Biopharma go back to January 2024, when the pharma first bet up to $4.165 billion across two RNAi agreements targeting cardiovascular diseases.
September 3, 2025
·
2 min read
·
Tristan Manalac
Deals
Novo’s $16.5B Deal with Catalent Gets Another 30 Days Added to FTC Antitrust Review
The Federal Trade Commission has asked for an additional 30 days for its review of Novo Nordisk’s $16.5 billion acquisition of Catalent, with the companies expecting to complete the merger by the end of 2024.
May 6, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Caidya Announces $165 Million Strategic Growth Investment From Rubicon Founders
January 13, 2025
·
3 min read
Press Releases
Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support
March 18, 2025
·
3 min read
Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment
Vessi Medical Ltd. (“Vessi”) announced today that it has closed a Series A financing round of $16.5 million for its cryotherapy technology to treat Non Muscle Invasive Bladder Cancer (“NMIBC”).
February 14, 2024
·
3 min read
1 of 2,664
Next
